A Phase Ⅱ Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small-Cell Lung Cancer: TORG2241 (UBE-Q)Shinji Nakamichi, Hiroaki Okamoto, Kotone Matsuyama et al.|Clinical Lung Cancer|2023Cited by 6